Harris Teeter pilots a mobile wallet solution as part of its online shopping service
WELLESLEY, Mass. — Paydiant, provider of a cloud-based mobile wallet, cardless ATM access and offer redemption platform, on Tuesday announced that Harris Teeter will deploy a pilot of Paydiant’s white label mobile wallet as part of their Express Lane online shopping service in Matthews, N.C. beginning this month.
“Harris Teeter is an innovative, service-oriented retailer that clearly strives to build and maintain loyalty among its customers in everything it does,” stated Chris Gardner, co-founder of Paydiant. “Paydiant’s white-label mobile wallet platform is as much about enhancing loyalty as it is about enabling mobile payments. That is where much of the value lies, and Harris Teeter is taking full advantage of those capabilities.”
The initial deployment will allow Harris Teeter Express Lane customers to use the Harris Teeter mobile wallet called “HT Express Pay” to pay for groceries ordered online. Payment will occur from within a customer’s vehicle at Express Lane curbside pick-up locations. Once the Harris Teeter mobile wallet app is downloaded to the customer’s iPhone or Android smartphone and payment cards are linked to the wallet, the customer will simply scan a QR code presented to them on a Verifone handheld mobile point of sale device. From there, the customer uses the mobile wallet to choose which of their major credit cards to use to complete the transaction, taps the “pay” button, and then a digital receipt is automatically sent to the customer’s mobile device.
Later this year, in an industry first for a large retailer, Harris Teeter also will accept other Paydiant-powered mobile wallets from banks and card-issuers in the HT Express Lane. Upon the successful pilot and in subsequent phases of the deployment, the Paydiant mobile wallet platform will be incorporated into Harris Teeter’s existing consumer-facing mobile application, ht mobile.
Swiss Precision launches pregnancy test that also provides an estimate of time since ovulation
PETIT LANCY, Switzerland — Swiss Precision Diagnostics recently launched its Clearblue Advanced Pregnancy Test with Weeks Estimator — the first and only pregnancy test that also provides an estimate of time since ovulation for women testing pregnant — into the U.S. marketplace.
As with other home pregnancy tests, the Clearblue Advanced Pregnancy Test with Weeks Estimator detects hCG, the hormone produced early in pregnancy and excreted in the urine. Uniquely, in addition to detecting hCG, the Clearblue Advanced Pregnancy Test with Weeks Estimator also measures the level of hCG to estimate time since ovulation.
The Weeks Estimator feature assumes ovulation occurred on the day after the urinary luteinizing hormone surge and works on a threshold basis of urinary hCG levels: there are three time bands that give an estimate of one to two, two to three, and three or more weeks. These thresholds are based on extensive research of urinary hCG rise in early pregnancy, the company reported.
The Clearblue Advanced Pregnancy Test with Weeks Estimator gives an estimate of time since ovulation that is 93% in agreement with time since ovulation is relative to the LH surge.
FDA approves Galderma’s Mirvaso for redness of rosacea
FORT WORTH, Texas — The Food and Drug Administration has approved a drug made by Galderma Labs for treating a side effect of rosacea in adults, the company said.
Galderma announced the approval of Mirvaso (brimonidine) topical gel in the 0.33% strength for the topical treatment of facial erythema of rosacea. The drug is applied once per day to reduce redness and lasts up to 12 hours. The company expects the drug to become available in pharmacies next month.
"Facial redness is the most common symptom of rosacea, but until now, physicians have been without prescription treatment options to specifically address this patient need," University of Louisville medical professor and lead investigator in the late-stage clinical trials of the drug Mark Jackson said. "The FDA approval of Mirvaso marks a turning point in rosacea treatment: We are now able to provide patients who deal with the daily frustrations caused by the redness of rosacea with an effective therapy."